Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse × inebilizumab × Clear all

NCT01453205 2018-03-12

A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Phase 2 Completed

187 enrolled 21 charts

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse